AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses - dofaq.co
AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses
Reuters - 15 Nov 2021
Two billion doses of the AstraZeneca-Oxford University COVID-19 vaccine have been supplied worldwide, the Anglo-Swedish drugmaker and its partner said on ...
AstraZeneca | Pharmaceuticals, Vaccines, & Facts
Britannica - 24 Apr 2025
AstraZeneca | Pharmaceuticals, Vaccines, & Facts ...
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR Newswire - 28 Apr 2025
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR ...
Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch'
Fierce Pharma - 28 Apr 2025
Daiichi Sankyo, AstraZeneca's highly touted ADC Datroway off to 'smooth market launch' ...
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
Reuters - 22 Apr 2025
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence ...
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
Business Wire - 23 Apr 2025
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology ...
China, America and pay inject drama into AstraZeneca’s AGM
The Guardian - 06 Apr 2025
China, America and pay inject drama into AstraZeneca’s AGM ...
AstraZeneca Young Health Programme
Unicef - 25 Nov 2024
AstraZeneca Young Health Programme ...
Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model
Fierce Biotech - 23 Apr 2025
Tempus AI in line for $200M from AstraZeneca, Pathos deal to develop cancer model ...
CEPI and AstraZeneca to advance discovery into novel antibody to help prevent infection during outbreaks
CEPI - 19 Mar 2025
CEPI and AstraZeneca to advance discovery into novel antibody to help prevent infection during outbreaks ...
AstraZeneca CEO says Europe is 'falling behind' on R&D and manufacturing investments
Endpoints News - 23 Apr 2025
AstraZeneca CEO says Europe is 'falling behind' on R&D and manufacturing investments ...
SOPHiA, AstraZeneca Expand Deployment of Liquid Biopsy Testing
marketscreener.com - 28 Apr 2025
SOPHiA, AstraZeneca Expand Deployment of Liquid Biopsy Testing ...
Corticosteroids Market SWOT Analysis by Key Players- AbbVie, AstraZeneca, Bayer
newstrail.com - 28 Apr 2025
Corticosteroids Market SWOT Analysis by Key Players- AbbVie, AstraZeneca, Bayer ...
What science can do
AstraZeneca US - 26 Mar 2025
What science can do ...
AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy
Clinical Trials Arena - 08 Apr 2025
AstraZeneca’s camizestrant gains momentum, but questions remain as first-line therapy ...
AstraZeneca H1 and Q2 2023 results - Investor Webcast
AstraZeneca - 25 Mar 2025
AstraZeneca H1 and Q2 2023 results - Investor Webcast ...
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos
Pharmaceutical Technology - 24 Apr 2025
AstraZeneca enters $200m AI cancer pact with Tempus and Pathos ...
AstraZeneca CEO says Europe must invest more to protect its 'health sovereignty'
Reuters - 24 Apr 2025
AstraZeneca CEO says Europe must invest more to protect its 'health sovereignty' ...
2 years after leaving PhRMA, AstraZeneca opts back in
Fierce Pharma - 22 Apr 2025
2 years after leaving PhRMA, AstraZeneca opts back in ...
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing
The Guardian - 21 Mar 2025
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing ...